Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

Cart
Checkout
Checkout
Comprehensive Drug Patent Profiles
Decision-Making for Generic Drug Entry and Branded Drug Lifecycle Management
Drug Patent News
DrugPatentWatch Insights Submission Form
DrugPatentWatch Report Store
DrugPatentWatch Report Store
DrugPatentWatch Reports Terms & Conditions
Excipient Business Development Profiles
My account
Courses
Checkout
Order Received
Order Failed
Terms & Conditions
Account

Drug Patent Expirations for the Week of June 2, 2024

By / June 5, 2024

ILEVRO (nepafenac)

Harrow eyePatent: 7,947,295Expiration: Jun 8, 2024

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Post navigation

Which pharmaceutical drugs have the most drug patents in Netherlands?

Which pharmaceutical drugs have the most drug patents in Poland?

New patent expiration for Arbor Pharms drug BIDIL

Patent Expiration / By

Patent delisted for Teva Pharms drug COPAXONE

Patent Expiration / By

Get Email Updates

Make Better Decisions

See Plans and Pricing

Drug Patent Reports

Shop now

Search for:

Make Better Decisions with DrugPatentWatch

Related Posts